Clinical trial reportCancerPublished
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neuroblastoma; Neoplasm Recurrence, Local; Cyclophosphamide; Topotecan; Piperidines; Pyrazoles; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Maximum Tolerated Dose; Dose-Response Relationship, Drug; Adolescent
- PubMed ID
- 39932800
- Added to directory
- Source checked